Candida resistance study pulled before it even started
NCT ID NCT07422194
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study was designed to learn more about different types of Candida fungus that cause serious bloodstream infections, especially during the COVID-19 pandemic. Researchers wanted to understand how these fungi become resistant to common antifungal drugs. However, the study was withdrawn before any participants were enrolled, so no new information was gathered.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
Conditions
Explore the condition pages connected to this study.